on ABIVAX (EPA:ABVX)
JP Morgan Chase exceeds 5% threshold in ABIVAX
On September 9, 2025, ABIVAX announced that JP Morgan Chase & Co. had exceeded the 5% threshold of its share capital. This crossing, recorded on September 5, resulted from an increase in the number of shares held through assimilation.
In total, JP Morgan holds 4,042,393 shares, representing 5.35% of the capital and 4.76% of the voting rights. This transaction primarily involves JP Morgan Prime Inc., JP Morgan Securities plc, and JP Morgan Securities LLC.
JP Morgan Securities LLC holds 3,603,156 shares through various contracts. In addition, this subsidiary holds 256,118 depository receipts. JP Morgan Securities plc also holds depository receipts.
The company also holds 77,848 shares through equity swap contracts, thus postponing its presence in ABIVAX's capital in the long term.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news